Medtronic Strikes Deal With Nile - Zacks.com PDF Print
Zacks.com
Medtronic (MDT - Analyst Report) recently entered into an agreement with Nile Therapeutics for the latter's proprietary peptide 'cenderitide', which is meant to treat heart failure and renal disease. Medtronic will provide adequate funding and offer

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.